Equine Exercise-Induced Pulmonary Hemorrhage – NAVLE Study Guide

Overview and Clinical Importance

Exercise-induced pulmonary hemorrhage (EIPH) is defined as the presence of blood in the airways of horses following strenuous exercise. EIPH is recognized as one of the most common conditions affecting performance horses and is considered a disease by the American College of Veterinary Internal Medicine (ACVIM). The condition occurs in virtually all horses undergoing high-intensity exercise, with prevalence rates of 45-75% detected by endoscopy and greater than 90% when bronchoalveolar lavage (BAL) cytology is used for diagnosis.

EIPH has been documented in equine athletes for over 300 years. The famous racehorse Bleeding Childers (born 1716), great grand-sire of the legendary Eclipse, was named for his tendency to exhibit epistaxis after racing. Despite our long awareness of this condition, the exact pathophysiology remains incompletely understood, and optimal treatment strategies continue to evolve.

Pathophysiology

Pulmonary Capillary Stress Failure

The fundamental cause of EIPH is pulmonary capillary stress failure. During maximal exercise, horses experience extraordinary cardiovascular demands that exceed the structural capacity of their pulmonary vasculature.

The exquisitely thin blood-gas barrier in horses (approximately 0.5 micrometers) allows for efficient gas exchange but is vulnerable to mechanical stress. When capillary transmural pressure exceeds approximately 75-100 mmHg, the structural integrity of this barrier fails, resulting in hemorrhage into the alveoli and interstitium.

Key Hemodynamic Changes During Exercise

During high-speed galloping, horses experience remarkable physiological changes:

• Cardiac output: Increases from approximately 30 L/min at rest to 250-300 L/min during maximal exercise
• Pulmonary arterial pressure: Increases 3-4 fold, reaching 80-120 mmHg
• Intrapleural pressure: Becomes highly negative (up to -40 to -50 mmHg during inspiration)
• Splenic contraction: Releases stored red blood cells, increasing hematocrit from approximately 40% to 60-65%
• Respiratory rate: Locked to stride frequency at 1:1 ratio (approximately 120-140 breaths/min at gallop)

Veno-Occlusive Remodeling

An important pathologic finding in horses with EIPH is pulmonary veno-occlusive remodeling. This involves:

• Concentric collagen deposition around small intralobular pulmonary veins
• Smooth muscle hypertrophy in venous walls
• Reduced venous compliance and luminal diameter
• Increased upstream capillary pressure during exercise

These changes are most pronounced in the caudodorsal lung fields, which correlates with the characteristic distribution of EIPH lesions. Whether veno-occlusive remodeling is a cause or consequence of repeated hemorrhage remains debated, but evidence suggests a self-perpetuating cycle of bleeding, inflammation, and structural change.

Anatomical Distribution

EIPH characteristically affects the caudodorsal lung fields. This regional predilection is attributed to several factors:

• Higher blood flow to caudodorsal regions during exercise
• Greater veno-occlusive remodeling in these areas
• Possible locomotory impact-induced stress (proposed but not proven)
• Regional differences in pulmonary capillary structure

Epidemiology and Risk Factors

Prevalence by Breed and Discipline

Risk Factors

Exam Focus: EIPH is a PROGRESSIVE disease. Repeated hemorrhagic episodes lead to inflammation, fibrosis, and hemosiderin deposition in the lungs. Moderate to severe EIPH and epistaxis are associated with shorter racing career duration.

Clinical Signs and Presentation

The clinical presentation of EIPH is often subtle. Most affected horses do NOT show overt clinical signs, which is why the condition is frequently underdiagnosed without post-exercise endoscopy.

Common Clinical Signs

• Poor athletic performance: Most common presenting complaint; sudden loss of speed during competition
• Excessive swallowing post-exercise: Indicates blood draining from airways into pharynx
• Coughing: During or immediately after exercise
• Epistaxis: Occurs in only 0.25-5% of affected horses (bilateral or unilateral)
• Prolonged recovery: Extended time to return to baseline respiratory rate after exercise
• Sudden death: Rare but reported; unclear if EIPH is primary cause or secondary finding

Diagnosis

Tracheobronchoscopy (Endoscopy)

Gold standard for field diagnosis. Optimal timing is 30-120 minutes after strenuous exercise. Blood may be detectable in the trachea for 1-3 days (up to 1 week in severe cases). Allows visualization of blood in the trachea and mainstem bronchi, and excludes other causes of hemorrhage (guttural pouch mycosis, ethmoid hematoma).

EIPH Endoscopic Grading Scale (0-4)

Bronchoalveolar Lavage (BAL)

Most sensitive diagnostic method. Useful when endoscopy cannot be performed within appropriate timeframe after exercise. Can detect EIPH days to weeks after hemorrhagic episode through identification of hemosiderophages (macrophages containing hemosiderin).

Cytologic Findings:

• Acute EIPH: Intact erythrocytes, erythrophagocytosis
• Subacute/Chronic EIPH: Hemosiderophages (golden-brown intracytoplasmic pigment)
• Special staining: Perls Prussian blue stain confirms hemosiderin (turns blue)

Thoracic Radiography

Limited diagnostic value for EIPH. May demonstrate alveolar or mixed alveolar-interstitial opacities in the caudodorsal lung fields. Many horses with EIPH have minimal or no radiographic abnormalities. Some horses without EIPH history may have marked changes. Most useful for ruling out other causes of respiratory disease.

Differential Diagnoses

When blood is detected in the upper or lower airways, the following conditions must be excluded:

Treatment and Management

Furosemide (Lasix/Salix)

Furosemide is the only treatment with high-quality evidence demonstrating efficacy in reducing EIPH severity. The 2015 ACVIM Consensus Statement made a weak recommendation for use of furosemide in management of racehorses with EIPH.

Mechanism of Action

• Loop diuretic causing significant diuresis and reduction in plasma volume
• Attenuates exercise-induced increases in right atrial, pulmonary arterial, and pulmonary capillary pressures
• Direct relaxation of pulmonary venous smooth muscle
• Net effect: Reduced transmural pressure across pulmonary capillaries

Dosing Protocol

Other Treatment Options

Management Strategies

• Increase race intervals: Longer rest between races may reduce EIPH severity
• Negative race pace strategy: Rating the horse early may be beneficial
• Avoid racing in extreme cold: When possible, given increased EIPH risk
• Optimize respiratory health: Treat concurrent lower airway inflammation/equine asthma
• Consider career change: For horses with severe, recurrent EIPH, transition to lower-intensity discipline
• Electrolyte replacement: Essential when using furosemide due to diuretic losses

Prognosis and Performance Impact

The impact of EIPH on racing performance is well-documented:

• Horses with EIPH Grade 2 or higher are 4.0 times less likely to win a race
• EIPH-affected horses are 1.8 times less likely to finish in the top three positions
• Horses with Grade 4 EIPH finish on average 6 meters behind Grade 0 horses
• Severe EIPH and epistaxis are associated with shorter racing career duration
• Horses with Grade 1 EIPH may not have significantly impaired performance

Exam Focus: EIPH is considered a PROGRESSIVE disease. Repeated hemorrhage leads to cumulative lung damage. Moderate to high quality evidence supports that EIPH worsens over time with continued racing, making early identification and management important.

Memory Aids and Board Tips

EIPH = "BLEED"

B - Breeds: Thoroughbreds, Standardbreds, Quarter Horses most affected

L - Location: Caudodorsal lung fields

E - Endoscopy: Gold standard diagnosis (30-120 min post-exercise)

E - Epistaxis: Rare (less than 5%) - absence does NOT rule out EIPH

D - Diuretic: Furosemide 0.5-1.0 mg/kg IV 4 hours pre-exercise

The "4-4-90" Rule for Furosemide

4 hours before exercise, 4 hours is the optimal timing, grade 4 EIPH covers greater than 90% of trachea WITH pooling

"STRESS Failure" Pathophysiology

S - Splenic contraction increases hematocrit

T - Transmural pressure exceeds capillary threshold

R - Remodeling of veins (veno-occlusive)

E - Exercise increases cardiac output 10-fold

S - Severe negative pleural pressure during inspiration

S - Sprint intensity (not duration) matters most